Abstract
AbstractDrug resistance to HIV‐1 protease involves the accumulation of multiple mutations in the protein. We investigate the role of these mutations by using molecular dynamics simulations that exploit the influence of the native‐state topology in the folding process. Our calculations show that sites contributing to phenotypic resistance of FDA‐approved drugs are among the most sensitive positions for the stability of partially folded states and should play a relevant role in the folding process. Furthermore, associations between amino acid sites mutating under drug treatment are shown to be statistically correlated. The striking correlation between clinical data and our calculations suggest a novel approach to the design of drugs tailored to bind regions crucial not only for protein function, but for folding as well. Proteins 2001;43:365–372. © 2001 Wiley‐Liss, Inc.
References
36
Referenced
33
10.1016/S0083-6729(00)58026-1
10.1146/annurev.bi.62.070193.002551
{'key': 'e_1_2_7_4_2', 'first-page': '567', 'article-title': 'A protease inhibitor for the treatment of patients with HIV‐1 infection', 'volume': '34', 'author': 'Reddy P', 'year': '1999', 'journal-title': 'Formulary'}
/ Formulary / A protease inhibitor for the treatment of patients with HIV‐1 infection by Reddy P (1999)10.1021/bi980386e
10.1038/374569a0
10.1089/088922299311420
10.1016/S0140-6736(98)12291-2
{'issue': '1', 'key': 'e_1_2_7_9_2', 'first-page': 'S15', 'article-title': 'Rational approaches to resistance: using saquinavir', 'author': 'Boucher C', 'year': '1996', 'journal-title': 'AIDS'}
/ AIDS / Rational approaches to resistance: using saquinavir by Boucher C (1996)10.1103/PhysRevLett.82.3372
10.1073/pnas.92.24.10869
10.1103/PhysRevLett.84.3009
10.1073/pnas.96.20.11299
10.1073/pnas.95.11.5872
10.1073/pnas.96.20.11305
10.1038/14890
10.1038/1418
10.1006/jmbi.2000.3693
10.1038/14896
10.1038/14901
10.1006/jmbi.1998.1645
10.1038/35011000
10.1126/science.181.4096.223
10.1126/science.7886447
10.1021/ma60052a001
10.1073/pnas.96.17.9616
10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R
10.1103/PhysRevA.28.1016
10.1103/PhysRevLett.63.1195
10.1016/S0378-4371(97)00222-7
10.1038/nm0796-760
10.1128/jvi.69.2.701-706.1995
10.1128/AAC.40.2.292
/ Antimicrob Agents Chemother / Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease by Patick AK (1996)10.1128/AAC.39.8.1704
10.1093/infdis/173.6.1379
10.1074/jbc.270.37.21433
10.1006/bbrc.1997.8008
Dates
Type | When |
---|---|
Created | 20 years, 10 months ago (Oct. 28, 2004, 11:35 p.m.) |
Deposited | 1 year, 11 months ago (Sept. 28, 2023, 5:36 p.m.) |
Indexed | 1 year ago (Aug. 12, 2024, 7:14 a.m.) |
Issued | 24 years, 4 months ago (April 26, 2001) |
Published | 24 years, 4 months ago (April 26, 2001) |
Published Online | 24 years, 4 months ago (April 26, 2001) |
Published Print | 24 years, 3 months ago (June 1, 2001) |
@article{Cecconi_2001, title={Molecular dynamics studies on HIV‐1 protease: Drug resistance and folding pathways}, volume={43}, ISSN={1097-0134}, url={http://dx.doi.org/10.1002/prot.1049}, DOI={10.1002/prot.1049}, number={4}, journal={Proteins: Structure, Function, and Bioinformatics}, publisher={Wiley}, author={Cecconi, Fabio and Micheletti, Cristian and Carloni, Paolo and Maritan, Amos}, year={2001}, month=apr, pages={365–372} }